NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases

A Fiordelisi, G Iaccarino, C Morisco, E Coscioni… - International journal of …, 2019 - mdpi.com
Inflammation is a key mechanism of cardiovascular diseases. It is an essential component of
atherosclerosis and a significant risk factor for the development of cardiovascular events. In …

Sympathetic nervous system overactivity and its role in the development of cardiovascular disease

SC Malpas - Physiological reviews, 2010 - journals.physiology.org
This review examines how the sympathetic nervous system plays a major role in the
regulation of cardiovascular function over multiple time scales. This is achieved through …

Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy

B Olshansky, HN Sabbah, PJ Hauptman, WS Colucci - Circulation, 2008 - Am Heart Assoc
Muscarinic receptors reside in both the atria and ventricles but have a greater density in the
former. 6 They occur more in the endocardium than in the epicardium. Muscarinic receptors …

[HTML][HTML] The role of the autonomic nervous system in sudden cardiac death

M Vaseghi, K Shivkumar - Progress in cardiovascular diseases, 2008 - ncbi.nlm.nih.gov
The cardiac autonomic nervous system consists of 2 branches—the sympathetic and the
parasympathetic systems—that work in a delicately tuned, yet opposing fashion in the heart …

Sympathetic nervous activation in obesity and the metabolic syndrome—causes, consequences and therapeutic implications

GW Lambert, NE Straznicky, EA Lambert… - Pharmacology & …, 2010 - Elsevier
The world wide prevalence of obesity and the metabolic syndrome is escalating. Contrary to
earlier experimental evidence, human obesity is characterised by sympathetic nervous …

[HTML][HTML] Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment

J Neumann, G Ligtenberg, II Klein, HA Koomans… - Kidney international, 2004 - Elsevier
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and
treatment. Cardiovascular morbidity and mortality importantly influence live expectancy of …

Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр)(утверждены конференцией ОССН 15 декабря 2009 года)

ВЮ Мареев, ФТ Агеев, ГП Арутюнов… - Журнал сердечная …, 2010 - elibrary.ru
Введение В короткой преамбуле хочется предпослать этому доку менту несколько
определяющих позиций: Принятие в 2003 и 2006 годах съездами ВНок Нацио 1 …

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

TB Horwich, WR MacLellan, GC Fonarow - Journal of the American College …, 2004 - jacc.org
Objectives: This study aimed to investigate the impact of hydroxymethylglutaryl coenzyme A
reductase inhibitor (statin) therapy in patients with advanced heart failure (HF). Background …

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure

S Sola, MQS Mir, BV Khan, S Lerakis… - Journal of the American …, 2006 - jacc.org
Objectives: This study examined the effect of statin therapy on vascular markers of
inflammation and echocardiographic findings in patients with nonischemic forms of …

Sympathetic hyperactivity in chronic renal failure: a wake-up call

HA Koomans, PJ Blankestijn… - Journal of the American …, 2004 - journals.lww.com
Sympathetic hyperactivity plays an important and distinct role in hypertension associated
with chronic renal failure (CRF). Renal ischemia, elevated angiotensin II, and suppressed …